Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · Real-Time Price · USD
0.8905
+0.0317 (3.69%)
At close: May 12, 2025, 4:00 PM
0.8930
+0.0025 (0.28%)
After-hours: May 12, 2025, 7:10 PM EDT
Clearside Biomedical Market Cap
Clearside Biomedical has a market cap or net worth of $68.82 million as of May 12, 2025. Its market cap has decreased by -31.25% in one year.
Market Cap
68.82M
Enterprise Value
101.27M
1-Year Change
-31.25%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since June 2, 2016, Clearside Biomedical's market cap has decreased from $142.00M to $68.82M, a decrease of -51.54%. That is a compound annual growth rate of -7.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 66.30M | -8.04% |
| Dec 31, 2024 | 72.10M | -1.23% |
| Dec 29, 2023 | 73.00M | 8.31% |
| Dec 30, 2022 | 67.40M | -58.93% |
| Dec 31, 2021 | 164.10M | 23.85% |
| Dec 31, 2020 | 132.50M | 11.06% |
| Dec 31, 2019 | 119.30M | 247.81% |
| Dec 31, 2018 | 34.30M | -80.67% |
| Dec 29, 2017 | 177.40M | -3.53% |
| Dec 30, 2016 | 183.90M | 29.51% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |